A Phase 1 interventional study of Placebo (to match Aspirin) and Aspirin in Healthy Volunteers, sponsored by Merck Sharp & Dohme LLC. Completed. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-08-13.
Sponsored by Merck Sharp & Dohme LLC (part of Merck & Co., Inc) · Phase 1, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study will evaluate whether the antiplatelet effects of Aspirin 300 mg daily and Clopidogrel 75 mg daily can be reproducibly measured using several point of care platelet function assays
Merck Sharp & Dohme LLC is the lead sponsor of 2,167 studies on the registry; 132 are open to participants now.
Of its 503 completed or terminated interventional studies of FDA-regulated products, 371 (74%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Aspirin - Clopidogrel - Placebo
Drug: Placebo (to match Aspirin) · Drug: Aspirin · Drug: Clopidogrel · Drug: Comparator: Placebo (to match Clopidogrel)
Clopidogrel - Placebo - Aspirin
Drug: Placebo (to match Aspirin) · Drug: Aspirin · Drug: Clopidogrel · Drug: Comparator: Placebo (to match Clopidogrel)
Placebo - Aspirin - Clopidogrel
Drug: Placebo (to match Aspirin) · Drug: Aspirin · Drug: Clopidogrel · Drug: Comparator: Placebo (to match Clopidogrel)
Aspirin - Placebo - Clopidogrel
Drug: Placebo (to match Aspirin) · Drug: Aspirin · Drug: Clopidogrel · Drug: Comparator: Placebo (to match Clopidogrel)
Clopidogrel - Aspirin - Placebo
Drug: Placebo (to match Aspirin) · Drug: Aspirin · Drug: Clopidogrel · Drug: Comparator: Placebo (to match Clopidogrel)
Placebo - Clopidogrel - Aspirin
Drug: Placebo (to match Aspirin) · Drug: Aspirin · Drug: Clopidogrel · Drug: Comparator: Placebo (to match Clopidogrel)
Placebo grossly matched Aspirin 300 mg daily
Aspirin 300 mg daily
Clopidogrel 75 mg daily
Placebo (grossly matched Clopidogrel 75 mg) daily
The effect size of light transmission platelet aggregation, bleeding time, and several point of care platelet function assays after 3 days of administration of study drug compared to placebo treatment.
Time frame: Baseline and 3 days
The intra-subject coefficient of variation of each of the 3 platelet function devices
Time frame: Baseline and 3 days
No study locations are listed for this record.
The record gives a start of Jun 2010, a primary completion of Aug 2010 and a completion of Aug 2010. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Aspirin · Clopidogrel